Ensemble Health Partners plans to commence the roadshow for its proposed IPO of 29.5 million shares priced between $19 and $22 each. The underwriters will have an option to purchase up to an additional 4.425 million. At the upper end of the range, Ensemble would have a market capitalization of about $649 million.
Ensemble has applied to list under ENSB on the Nasdaq.
Ensemble intends to use the net proceeds from the offering to repay a portion of its outstanding term loan, to purchase equity interests from certain existing stockholders, to pay expenses incurred in connection with the offering and, to the extent there are any remaining proceeds, for working capital and other general corporate purposes.
Goldman Sachs, BofA Securities, Deutsche Bank and Guggenheim are joint lead book-running managers for the offering. Credit Suisse, Evercore ISI, Wells Fargo Securities, SVB Leerink, Baird, and William Blair are joint book-runners. Academy Securities and Loop Capital Markets are co-managers. Read more.
